FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 12.1

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

2.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.12 (-0.36%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.10 (-0.20%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.07 (-0.24%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.10 (-0.40%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.08 (-0.23%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.01%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.37 (-0.78%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.04 (-0.14%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.05 (-0.45%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.05 (+0.22%)

CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.18% 50% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.18% 49% F 45% F
Trailing 12 Months  
Capital Gain -4.65% 12% F 21% F
Dividend Return 1.72% 45% F 31% F
Total Return -2.93% 11% F 20% F
Trailing 5 Years  
Capital Gain 6.23% 37% F 35% F
Dividend Return 32.29% 86% B+ 75% C
Total Return 38.52% 42% F 39% F
Average Annual (5 Year Horizon)  
Capital Gain 3.82% 52% F 47% F
Dividend Return 4.51% 52% F 43% F
Total Return 0.69% 68% D+ 29% F
Risk Return Profile  
Volatility (Standard Deviation) 4.91% 81% B- 92% A
Risk Adjusted Return 91.74% 94% A 90% A-
Market Capitalization 0.05B 45% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.